|
Volumn 69, Issue 2 SUPPL., 2001, Pages
|
Newer drugs in leprosy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CLARITHROMYCIN;
CLOFAZIMINE;
CYCLINE;
DAPSONE;
LEPROSTATIC AGENT;
MACROLIDE;
MINOCYCLINE;
MOXIFLOXACIN;
OFLOXACIN;
PEFLOXACIN;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
RIFAMPICIN;
RIFAMYCIN;
RIFAPENTINE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
BACTERICIDAL ACTIVITY;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG POTENCY;
HUMAN;
LEPROSY;
LEPROSY CONTROL;
MOUSE;
MYCOBACTERIUM LEPRAE;
NONHUMAN;
SIDE EFFECT;
ANIMALS;
CLINICAL TRIALS;
DRUG THERAPY, COMBINATION;
FOOT;
HUMANS;
LEPROSTATIC AGENTS;
LEPROSY;
MICE;
MICROBIAL SENSITIVITY TESTS;
MYCOBACTERIUM LEPRAE;
TREATMENT OUTCOME;
|
EID: 0035189906
PISSN: 0148916X
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (28)
|
References (32)
|